Pfizer Raises Annual Sales Forecast to $62 Billion–$64 Billion
Pfizer cited momentum in newly launched and acquired products, which helped offset declining sales of its Covid-19 vaccine and treatments.
By Kelly CloonanPfizer boosted its guidance for the year, citing momentum in newly-launched and acquired products that helped offset declining sales for its Covid-19 vaccine and treatments.The drug and vaccine maker said Tuesday it now projects sales of $62 billion to $64 billion this year, up from…